Right upper quadrant pain is one of the most frequent reasons for consultations in the emergency room. Gallbladder pathology is among the most common etiologies and can include cholecystitis, cholelithiasis, choledocholithiasis, and cholangitis, among others. Mirizzi syndrome is a complication that manifests as hepatobiliary dysfunction due to a gallstone causing extrinsic compression of the common bile duct. However, acute cholecystitis can externally obstruct the common bile duct and mimic Mirizzi syndrome in the absence of a causative gallstone. The relevance of this syndrome lies in its timely imaging diagnosis, allowing physicians to rule out other biliary pathologies and to identify its different presentations before surgical intervention. A 72-year-old male presented with abdominal pain in the right upper quadrant for the past four days. The pain persisted, prompting his admission to the emergency department. On examination, he reported abdominal pain with a positive Murphy sign. Initial abdominal ultrasound revealed dilation of the common hepatic duct, hydrocholecyst, and thickening of the gallbladder wall. Abdominal computed tomography (CT) suggested extrinsic compression of the extrahepatic bile duct by the gallbladder. Laboratory tests revealed significant leukocytosis with neutrophilia, and inflammatory markers, including C-reactive protein and erythrocyte sedimentation rate, were elevated. Liver function tests, however, remained within normal limits, with only a slight elevation in gamma-glutamyl transferase (GGT). Magnetic resonance imaging with gadolinium ruled out neoplasia of the pancreas. A magnetic resonance cholangiopancreatography (MRCP) confirmed dilation of the extrahepatic bile duct caused by extrinsic compression from the gallbladder infundibulum at the hepatic hilum and proximal common bile duct, along with slight dilation of the intrahepatic bile duct. Hydrocholecyst and gallbladder wall thickening with signal changes due to edema were also observed. These findings confirmed an extremely rare alithiasic presentation of type I Mirizzi syndrome. The patient was offered a cholecystectomy; however, he declined surgical treatment. Conservative management was pursued, and a follow-up ultrasound performed two days later showed a significant reduction in gallbladder volume, correlating with clinical improvement.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11872011 | PMC |
http://dx.doi.org/10.7759/cureus.78261 | DOI Listing |
Front Immunol
March 2025
Department of Clinical Laboratory, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Cholangiocarcinoma (CCA), a malignant tumor, is typically challenging to detect early and often results in a poor prognosis. In recent years, research interest has grown in the potential application of immunotherapy for CCA treatment. T cells, as a crucial component of the immune system, play a significant role in immune surveillance and therapy for cholangiocarcinoma.
View Article and Find Full Text PDFCureus
February 2025
Gastroenterology and Hepatology, Baylor Scott & White All Saints Medical Center, Fort Worth, USA.
Intraductal papillary mucinous neoplasms (IPMNs) are a prevalent subtype of pancreatic cystic lesions, especially among individuals with liver cirrhosis. Intraductal papillary neoplasms of the bile duct (IPNBs) differ in histopathology based on the location and cellular variability in each location. Intrahepatic IPNBs are less aggressive than the extrahepatic variant, highlighting its heterogeneity and complexity.
View Article and Find Full Text PDFCureus
February 2025
Gastroenterology, Icahn School of Medicine at Mount Sinai, Queens, USA.
Hepatolithiasis is a condition characterized by the presence of bile stones in the intrahepatic bile ducts. It represents a significant therapeutic challenge owing to its association with recurrent cholangitis, biliary obstruction, and potentially life-threatening complications such as hepatic abscesses and cholangiocarcinoma. Traditional treatments include hepatectomy and percutaneous transhepatic cholangioscopic lithotomy (PTCL), both of which are effective but highly invasive, whereas endoscopic approaches often leave residual stones.
View Article and Find Full Text PDFBMC Gastroenterol
March 2025
Department of General Surgery, Qena Faculty of Medicine, South Valley University, Qena city, Egypt.
Background: The management of patients with concomitant gallbladder stones with silent CBDS still involves a wide range of debates, and there is little evidence regarding the recommendation of CBD clearance either before cholecystectomy or in the same session. In this study, we aimed to discuss the feasibility of performing LC with a wait-and-see strategy for patients with silent CBS.
Method: Patients with silent CBDS identified during preoperative examinations for gallbladder stones were studied for the feasibility of performing LC with a wait-and-see strategy for silent CBS.
NPJ Genom Med
March 2025
Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA.
Programmed cell death protein 1 (PD-1) is a critical immune checkpoint receptor and a target for cancer immune checkpoint inhibitors (ICI). We investigated PD-1 transcript expression across cancer types and its correlations to clinical outcomes. Using a reference population, PD-1 expression was calculated as percentiles in 489 of 514 patients (31 cancer types) with advanced/metastatic disease.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!